Evidence map›Paper›PMID 40463597›Full record

ArticleRespiratory medicine case reports2025

Chylothorax complicating extrathoracic sarcoidosis.

Tarik Al-Bermani, Ralph Sabang, Oleg Epelbaum

Abstract readCase Reports
In one paragraph

Article in Respiratory medicine case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tarik Al-BermaniDivision of Pulmonary and Critical Care Medicine, NYC Health+Hospitals/Kings County, Brooklyn, NY, USA.
Ralph SabangDivision of Pulmonary, Critical Care and Sleep Medicine, Westchester Medical Center, Valhalla, NY, USA.
Oleg EpelbaumDivision of Pulmonary, Critical Care and Sleep Medicine, Westchester Medical Center, Valhalla, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinically significant pleural effusion is an extremely rare manifestation of sarcoidosis. Chylothorax associated with sarcoidosis is an even rarer phenomenon reported in the literature only as individual cases. According to the available literature, whenever chylothorax has occurred in the setting of sarcoidosis, this has almost invariably been in the setting of lymphadenopathy or at least in the setting of prior or concurrent evidence of thoracic sarcoidosis. We describe a patient with biopsy-proven abdominal sarcoidosis who developed chylothorax in the absence of lymphadenopathy or thoracic involvement and whose chylothorax rapidly and durably resolved after resumption of corticosteroid therapy.

Indexed as

ChylothoraxPleural effusionSarcoidosis

Identifiers

PMID40463597
PMCPMC12127855

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.